MEDIPOSTCO.,LTD.

Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.

078160 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
Website:: https://en.medi-post.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDIPOST CO., LTD. is a global biotechnology company specializing in the development and commercialization of umbilical cord blood-derived stem cell therapeutics. The company focuses on regenerative medicine to address unmet medical needs. Its commercialized portfolio includes first-generation products such as CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. Alongside its therapeutic endeavors, MEDIPOST operates a significant private cord blood banking division for the collection and storage of stem cells. The company's research and development pipeline includes next-generation injectable and intravenous treatments for conditions like osteoarthritis (SMUP-IA-01) and diabetic nephropathy (SMUP-IV-01).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MEDIPOSTCO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-03 00:00	Pre-Annual General Meeting Information 주주명부폐쇄기간또는기준일설정	Korean	4.4 KB
2025-09-01 00:00	Report Publication Announcement 기업설명회(IR)개최	Korean	7.4 KB

Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Klaria Pharma Holding AB Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.	Sweden	KLAR
KOA SHOJI HOLDINGS CO.,LTD. Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.	Japan	9273
KOBAYASHI PHARMACEUTICAL CO.,LTD. Manufactures OTC pharma, personal care, and household goods for niche consumer markets.	Japan	4967
Kohjin Bio Co., Ltd. A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.	Japan	177A
KOLON LIFE SCIENCE Inc. Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.	South Korea	102940
Kolon TissueGene, Inc. Developing cell and gene therapies for orthopedic and degenerative disorders.	United States of America	950160
KOMIPHARM INTERNATIONAL CO., LTD. Develops animal health products and novel drugs for human cancer and autoimmune diseases.	South Korea	041960
KOREA ARLICO PHARM CO.,LTD. Manufactures generic drugs and provides CDMO services to a global market.	South Korea	260660
KOREAN DRUG CO., LTD. Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.	South Korea	014570
K Pharma,Inc. Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.	Japan	4896